Protara Therapeutics, Inc. (PRTO) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K/A
Revenues [+]	0.0	50.2	0.0	0.0	0.0	0.0	0.0	12.4
Royalties								12.4
Net investment income	0.0
Revenue growth	-99.9%						-100.0%	320.0%
Cost of goods sold	-70.5	0.0	0.0	0.0	0.0	0.0	0.0	20.9
Gross profit	70.5	50.2	0.0	0.0	0.0	0.0	0.0	-8.5
Gross margin	207417.6%	100.0%						-68.6%
Selling, general and administrative [+]	21.0	26.6	22.5	4.0	9.5	8.7	9.8	8.5
General and administrative [+]	21.0	26.6	22.5	4.0	9.5	8.7	9.8	8.5
Wages and related expenses	0.2	0.2
General and administrative expenses	20.7	26.4	22.5	4.0	9.5	8.7	9.8	8.5
Research and development	16.8	21.1	12.0	3.9	11.8	21.7	18.9
Other operating expenses	70.3	50.0						3.9
EBITDA [+]	-37.3	-47.4	-34.3	-7.8	-21.3	-30.2	-28.6
EBITDA growth	-21.3%	37.9%	339.5%	-63.2%	-29.6%	5.7%	37.0%	175.3%
EBITDA margin	-109697.1%	-94.4%						-168.6%
Depreciation and amortization	0.2	0.1	0.1	0.0	0.1	0.1	0.1
EBIT [+]	-37.5	-47.5	-34.4	-7.8	-21.4	-30.4	-28.7	-20.9
EBIT growth	-20.9%	37.9%	339.9%	-63.4%	-29.6%	5.8%	37.5%	175.3%
EBIT margin	-110426.5%	-94.6%						-168.6%
Non-recurring items [+]	29.5
Asset impairment	29.5
Interest income, net [+]	1.1	0.2	0.5		0.4	0.3	0.2
Interest expense			0.0
Interest income	1.1	0.2	0.5		0.4	0.3	0.2
Other income (expense), net [+]					0.2	0.1	0.0	-0.5
Other					0.2	0.1	0.0	-0.7
Pre-tax income	-66.0	-47.3	-34.0	-7.8	-20.7	-30.0	-28.5	-21.4
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-66.0	-47.3	-34.0	-7.8	-20.7	-36.7	-28.5	-21.4
Net margin	-193976.5%	-94.1%						-172.7%

Basic EPS [+]	($5.86)	($4.21)	($4.70)	($3.04)	($45.80)	($2.13)	($1.72)	($21,377.00)
Growth	39.2%	-10.4%	54.6%	-93.4%	2055.3%	23.4%	-100.0%	120.5%
Diluted EPS [+]	($5.86)	($4.21)	($4.70)	($3.04)	($45.80)	($2.13)	($1.72)	($1.31)
Growth	39.2%	-10.4%	54.6%	-93.4%	2055.3%	23.4%	31.4%	-100.0%

Shares outstanding (basic) [+]	11.3	11.2	7.2	2.6	0.5	17.3	16.6	0.0
Growth	0.2%	55.3%	180.7%	469.5%	-97.4%	4.3%	1656079.9%	190.1%
Shares outstanding (diluted) [+]	11.3	11.2	7.2	2.6	0.5	17.3	16.6	16.3
Growth	0.2%	55.3%	180.7%	469.5%	-97.4%	4.3%	1.5%	1631112.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.